Health News - Diabetic Life. Learn about Juvenile Diabetes, Heart Disease, Glucose testing and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Diabetes Drug Helps Dieting Teens Lose Weight

Metformin plus lifestyle changes might play a role in obesity treatment, researchers say

MONDAY, Feb. 1 (HealthDay News) -- A medication used to treat type 2 diabetes appears to help overweight teenagers lose weight when combined with a program designed to help them change their lifestyle habits, researchers report.

The obese kids who took the drug, metformin XR, lost a small but statistically significant amount of weight, says a study in the February issue of Archives of Pediatrics & Adolescent Medicine.

Advertisement
Related Stories
 border=
Many Americans Don't Even Know They're Fat
Immune System Research Sees Many Similarities Among People
Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice
Related Videos
 border=
Removing Tumors Through the Nose
Kids Diagnosing Themselves
Reversing Nerve Damage
Related Slides
 border=
Diabetes
Thyroid Disease
Diabetic Retinopathy
Related Encyclopedia
 border=
Addison's Disease
Carcinoid Syndrome
Congenital Adrenal Hyperplasia


According to the study, almost a third of American children are overweight or obese, conditions that put them at high risk for type 2 diabetes and high blood pressure.

While some doctors use metformin to treat non-diabetic fat teens, it hasn't been clear if it actually works.

Researchers enrolled 77 fat adolescents, aged 13 to 18, in a program designed to boost their physical activity and help them control their diet. Some received a placebo, while others got a daily dose of 2,000 milligrams of metformin XR.

Over a year, the average body-mass index -- a measurement of weight in relation to height -- fell by 0.9 in the metformin group but grew by 0.2 in those who took a placebo.

"Metformin was safe and tolerated in this population. These results indicate that metformin may have an important role in the treatment of adolescent obesity," the authors concluded. "Longer-term studies will be needed to define the effects of metformin treatment on obesity-related disease risk in this population."

More information

The U.S. National Library of Medicine has more on metformin.

-- Randy Dotinga

SOURCE: American Medical Association, Feb. 1, 2010

Copyright © 2010 HealthDay. All rights reserved.
Last updated 2/1/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Sep 4, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Diabetes Connections
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: